↓ Skip to main content

Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL

Overview of attention for article published in BMC Cancer, October 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

twitter
34 X users

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
61 Mendeley